Amicus Therapeutics, Inc.Amicus Therapeutics, Inc.Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc.

No trades
See on Supercharts

FOLD fundamentals

Amicus Therapeutics, Inc. key financial stats and ratios

FOLD price-to-sales ratio is 7.25. The company has an Enterprise Value to EBITDA ratio of 159.25. As of 2023 they employed 517 people.

Statistics
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios